Advertisement

Lymphoproliferative Diseases and Kaposi’s Sarcoma in Homosexual Males

  • Donald Abrams

Abstract

On July 3, 1981, the Centers for Disease Control (CDC) in Atlanta, Georgia reported ten cases of Pneumocystis carinii pneumonia (PCP) and 22 cases of Kaposi’s sarcoma (KS) in previously healthy young homosexual men (1). A syndrome of acquired immunodeficiency (AIDS) underlies the appearance of these often fatal illnesses in this subpopulation of male homosexuals (2–9). The problem has reached epidemic proportions with 1.2 new cases being reported to the CDC daily. More men have died as a consequence of this syndrome than the combined total of all deaths from toxic shock syndrome and the initial outbreak of Legionnaire’s disease. With the recognition of AIDS in heterosexual patients predominantly intravenous drug abusers, Haitian nationals and refugees, and a few hemophiliacs (10,11) — investigations to define the etiology of the underlying immune dysfunction have been intensified. Clustering of cases in the homosexual community has implied a transmissible agent is responsible for AIDS (12). A viral etiology seems most plausible. The possibility of an underlying genetic predisposition to aberrant handling of a common viral infection is reminiscent of the model of Purtilo’s X-linked lymphoproliferative syndrome (13–16).

Keywords

Primary Central Nervous System Lymphoma Pneumocystis Carinii Pneumonia Homosexual Male Viral Capsid Antigen Secondary Primary Malignancy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Friedmari-Kien, A., Laubenstein, L., Marmor, M. et al. Kaposi’s sarcoma and Pneumocystis pneumonia among homosexual men — New York City and California. Morbid. Mortal. Week. Rev., 30:305, 1981.Google Scholar
  2. 2.
    Gottlieb, M.S., Schroff, R., Schanker, H., Weisman, J.D., Peng, T.F., Wolf, R.A., and Saxon, A. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men. Evidence of a new acquired cellular immunodeficiency. N. Engl. J. Med., 305:1425, 1981.PubMedCrossRefGoogle Scholar
  3. 3.
    Levine, A.S. The epidemic of acquired immune dysfunction in homosexual men and its sequelae — opportunistic infections, Kaposi’s sarcoma, and other malignancies: an update and interpretation. Cancer Treat. Rep., 66:391, 1982.Google Scholar
  4. 4.
    Masur, H., Michelis, M.A., Greene, J.B., Onorato, I., Vande Stouwe, R.A., Holzman, R.S., Wormser, G., Brettman, L., Lange, M., Murray, H.W., and Cunningham-Rundles, S. An outbreak of community-acquired Pneumocystis carinii pneumonia. Initial manifestation of cellular immune dysfunction. N. Engl. J. Med., 305:1431, 1981.PubMedCrossRefGoogle Scholar
  5. 5.
    Siegal, F.P., Lopez, C., Hammer, G.S., Brown, A.E., Kornfeld, S.J., Gold, J., Hassett, J., Hirshman, S.Z., Cunningham-Rundles, C., Adelsberg, B.R., Parham, D.M., Siegal, M., Cunningham-Rundles, S., and Armstrong, D. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N. Engl. J. Med., 305:1439, 1981.PubMedCrossRefGoogle Scholar
  6. 6.
    Gottlieb, G.J., Ragaz, A., Vogel, J.V., Friedman-Kien, A., Rywlin, A.M., Weiner, E.A., and Ackerman, A.B. A preliminary communication on extensively disseminated Kaposi’s sarcoma in young homosexual men. Am. J. Dermatopathol., 3:111, 1981.PubMedCrossRefGoogle Scholar
  7. 7.
    Hymes, K.B., Greene, J.B., Marcus, A., William, D.C., Cheung, T., Prose, N.S., Ballard, H., and Laubenstein, L.J. Kaposi’s sarcoma in homosexual men — A report of eight cases. Lancet, ii:598, 1981.CrossRefGoogle Scholar
  8. 8.
    Mildvan, D., Mathur, U., Enlow, R.W., Romain, P.L., Winchester, R.J., Colp, C., Singman, H., Adelsberg, B.R., and Spigland, I. Opportunistic infections and immune deficiency in homosexual men. Ann. Intern. Med., 96:700, 1982.PubMedGoogle Scholar
  9. 9.
    Follansbee, S.E., Busch, D.F., Wofsy, C.B., Coleman, D.L., Gullet, J., Aurigemma, G.P., Ross, T., Hadley, W.K., and Drew, W.L. An outbreak of Pneumocystis carinii pneumonia in homosexual men. Ann. Intern. Med., 96:705, 1982.PubMedGoogle Scholar
  10. 10.
    Hensley, G.T., Moskowitz, L.B., Pitchenik, A.E. et al. Opportunistic infections among Haitians in the United States. Morbid. Mortal. Week. Rev., 31:353, 1982.Google Scholar
  11. 11.
    Ehrenkranz, N.J., Rubini, J., Gunn, R. et al. Pneumocystis carinii pneumonia among persons with hemophilia A. Morbid. Mortal. Week. Rep., 31:365, 1982.Google Scholar
  12. 12.
    Fannin, S., Gottlieb, M.S., Weisman, J.D. et al. A cluster of Kaposi’s sarcoma and Pneumocystis carinii pneumonia among homosexual male residents of Los Angeles and Orange Counties, California. Morbid. Mortal. Week. Rep., 31:305, 1982.Google Scholar
  13. 13.
    Purtilo, D.T., Paquin, L., DeFlorio, D., Virzi, F., and Sakhuja, R. Immunodiagnosis and immunopathogenesis of the X-linked recessive lymphoproliferative syndrome. Sem. Hematol., 16:309, 1979.Google Scholar
  14. 14.
    Purtilo, D.T. Epstein-Barr virus-induced oncogenesis in immune-deficient individuals. Lancet, i:300, 1980.CrossRefGoogle Scholar
  15. 15.
    Purtilo, D.T. Immune deficiency predisposing to Epstein-Barr virus-induced lymphoproliferative diseases: the X-linked lymphoproliferative syndrome as a model. Advan. Cancer Res., 34:279, 1981.CrossRefGoogle Scholar
  16. 16.
    Purtilo, D.T. and Klein, G. Introduction to Epstein-Barr virus and lymphoproliferative diseases in immunodefi-cient individuals. Cancer Res., 41:4209, 1981.PubMedGoogle Scholar
  17. 17.
    Ziegler, J.L., Wagner, G., Greenspan, J.S. et al. Diffuse undifferentiated non-Hodgkin’s lymphoma among homosexual males — United States. Morbid. Mortal. Week. Rev., 31:277, 1982.Google Scholar
  18. 18.
    Mildvan, D., Mathur, U., Enlow, R. et al. Persistent, generalized lymphadenopathy among homosexual males. Morbid. Mortal. Week. Rep., 31:249, 1982.Google Scholar
  19. 19.
    Kaposi, M. Idiopathigches multiples pigment sarcom der Haut. Arch. Dermatol. Syph., 4:265, 1872.Google Scholar
  20. 20.
    Safai, B. and Good, R.A. Kaposi’s sarcoma: a review and recent developments. Cancer, 31:2, 1981.Google Scholar
  21. 21.
    Harwood, A.R., Osoba, D., Hofstader, S.L., Goldstein, M.B., Cardella, C.J., Holecek, M.J., Kunynetz, R., and Giammarco, R.A. Kaposi’s sarcoma in recipients of renal transplants. Am. J. Med., 67:759, 1979.PubMedCrossRefGoogle Scholar
  22. 22.
    Klepp, O., Dahl, O., and Stenwig, J.T. Association of Kaposi’s sarcoma and prior immunosuppressive therapy. A 5-year material of Kaposi’s sarcoma in Norway. Cancer, 42:2626, 1978.PubMedCrossRefGoogle Scholar
  23. 23.
    Myers, B.D., Kesler, E., and Levi, J. Kaposi’s sarcoma in kidney transplant recipients. Arch. Int. Med., 133:307, 1974.CrossRefGoogle Scholar
  24. 24.
    Auerbach, D.M., Bennett, J.V., Brachman, P.S. et al. Epidemiologic aspects of the current outbreak of Kaposi’s sarcoma and opportunistic infections. N. Engl. J. Med., 306:248, 1982.Google Scholar
  25. 25.
    Bhana, D., Templeton, A.C., Master, S.P., and Kyalwazi, S.K. Kaposi sarcoma of lymph nodes. Br. J. Cancer, 24:464, 1970.PubMedCrossRefGoogle Scholar
  26. 26.
    Finkbeiner, W.E., Egbert, B.M., Groundwater, J.R., and Sagebiel, R.W. Kaposi’s sarcoma in young homosexual men. Arch. Pathol. Lab. Med., 106:261, 1982.PubMedGoogle Scholar
  27. 27.
    Safai, B., Mike, V., Giraldo, G., Beth, E., and Good, R.A. Association of Kaposi’s sarcoma with secondary primary malignancies. Possible etiopathogenic implications. Cancer, 45:1472, 1980.PubMedCrossRefGoogle Scholar
  28. 28.
    Ulbright, T.M. and Santa Cruz, D.J. Kaposi’s sarcoma: relationship with hematologic, lymphoid, and thymic neoplasia. Cancer, 47:963, 1981.PubMedCrossRefGoogle Scholar
  29. 29.
    Sinclair, S., Beckman, E., and Ellman, L. Biopsy of enlarged, superficial lymph nodes. J. Am. Med. Asoc., 228:602, 1974.CrossRefGoogle Scholar
  30. 30.
    Schroer, K.R. and Franssila, K.O. Atypical hyperplasia of lymph nodes. A follow-up study. Cancer, 44:1155, 1979.PubMedCrossRefGoogle Scholar
  31. 31.
    Ammann, A., Abrams, D., Conant, M., Chudwin, D., Cowan, M., Volberding, P., Lewis, B., and Casavant, C. Acquired immune dysfunction in homosexual men: immunologic profiles. Clin. Immunol., 1982.Google Scholar
  32. 32.
    Stahl, R.E., Friedman-Kien, A., Dubin, R., Marmor, M., and Zolla-Pazner, S. Immunologic abnormalities in homosexual men. Relationship to Kaposi’s sarcoma. Am. J. Med., 73:171, 1982.PubMedCrossRefGoogle Scholar
  33. 33.
    Reinherz, E.L., O’Brien, C., Rosenthal, P., and Schlossman, S.F. The cellular basis for viral-induced immunodeficiency: analysis by monoclonal antibodies. J. Immunol., 125:1269, 1980.PubMedGoogle Scholar
  34. 34.
    Tosato, G., Magrath, I., Koski, I., Dooley, N., and Blaese, M. Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis. N. Engl. J. Med., 301:1133, 1979.PubMedCrossRefGoogle Scholar
  35. 35.
    Giraldo, G., Beth, E., Coeur, P. et al. Kaposi’s sarcoma: a new model in the search for viruses associated with human malignancies. J. Natl. Cancer Inst., 49:1495, 1972.PubMedGoogle Scholar
  36. 36.
    Giraldo, G., Beth, E., and Haguenau, F. Herpes-type virus particles in tissue culture of Kaposi’s sarcoma from different geographic regions. J. Natl. Cancer Inst., 49:1509, 1972.PubMedGoogle Scholar
  37. 37.
    Giraldo, G., Beth, E., Kourilsky, F.M., Henle, W., Henle, G., Mike, V., Huraux, J.M., Andersen, H.K., Gharbi, M.R., Kyalwazi, S.K., and Puissant, A. Antibody patterns to herpesviruses in Kaposi’s sarcoma: serological association of European Kaposi’s sarcoma with cytomegalovirus. Int. J. Cancer, 15:839, 1975.PubMedCrossRefGoogle Scholar
  38. 38.
    Giraldo, G., Beth, E., Henle, W., Mike, V., Safai, B., Huraux, J.M., McHardy, J., and De The, G. Antibody patterns to herpesviruses in Kaposi’s sarcoma. II. Serological association of American Kaposi’s sarcoma with cytomegalovirus. Int. J. Cancer, 22:126, 1978.PubMedCrossRefGoogle Scholar
  39. 39.
    Giraldo, G., Beth, E., Hammerling, U., Tarro, G., and Kowrilsky, F.M. Detection of early antigens in nuclei of cells infected with cytomegalovirus or herpes simplex virus type 1 and 2 by anti-complement immunofluorescence, and use of a blocking assay to demonstrate their specificity. Int. J. Cancer, 19:107, 1977.PubMedCrossRefGoogle Scholar
  40. 40.
    Giraldo, G., Beth, E., and Huang, E.-S. Kaposi’s sarcoma and its relationship to cytomegalovirus (CMV). III. CMV DNA and CMV early antigens in Kaposi’s sarcoma. Int. J. Cancer, 26:23, 1980.PubMedCrossRefGoogle Scholar
  41. 41.
    Drew, W.L., Mintz, L., Miner, R.C., Sands, M., and Ketterer, B. Prevalence of cytomegalovirus infection in homosexual men. J. Infect. Dis., 143:188, 1981.PubMedCrossRefGoogle Scholar
  42. 42.
    Drew, W.L., Miner, R.C., Ziegler, J.L., Gullet, J.H., Abrams, D.I., Conant, M.A., Huang, E.-S., Groundwater, J.R., Volberding, P., and Mintz. L. Cytomegalovirus and Kaposi’s sarcoma in young homosexual men. Lancet, ii:125, 1982.CrossRefGoogle Scholar
  43. 43.
    Ziegler, J.L., Magrath, I.T., Gerber, P., and Levine, P.H. Epstein-Barr virus and human malignancy. Ann. Intern. Med., 86:323, 1977.PubMedGoogle Scholar
  44. 44.
    de The, G., Geser, A., Day, N.E., Tukei, P.M., Williams, E.H., Beri, D.P., Smith, P.G., Dean, A.G., Bornkamm, G.W., Feorino, P., and Henle, W. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt’s lymphoma from Ugandan prospective study. Nature, 274:756, 1978.CrossRefGoogle Scholar
  45. 45.
    Ziegler, J.L. Burkitt’s lymphoma. N. Engl. J. Med., 305:735, 1981.PubMedCrossRefGoogle Scholar
  46. 46.
    Henle, G., Henle, W., Clifford, P., Diehl, V., Kafuko, G.W., Kirya, B.G., Klein, G., Morrow, R.H., Munube, G.M.R., Pike, P., Tukei, P.M., and Ziegler, J.L. Antibodies to Epstein-Barr virus in Burkitt’s lymphoma and control groups. J. Natl. Cancer Inst., 43:1147, 1969.PubMedGoogle Scholar
  47. 47.
    Klein, G., Giovanella, B.C., Lindahl, T., Fialkow, P.J., Singh, S., and Stehlin, J.S. Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc. Natl. Acad. Sci. USA, 71:4737, 1974.PubMedCrossRefGoogle Scholar
  48. 48.
    Purtilo, D.T., Bhawan, J., Hutt, L.M., DeNicola, L., Szymanski, I., Yange, J.P.S., Boto, W., Maier, R., and Thorley-Lawson, D. Epstein-Barr virus infections in the X-linked recessive lymphoproliferative syndrome. Lancet, i:798, 1978.CrossRefGoogle Scholar
  49. 49.
    Hanto, D.W., Frizzera, G., Gajl-Peczalska, K.J., Sakamoto, K., Purtilo, D.T., Balfour, H.H., Jr., Simmons, R.L., and Najarian, J.S. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation. N. Engl. J. Med., 306:913, 1982.PubMedCrossRefGoogle Scholar
  50. 50.
    Purtilo, D.T., Sakamoto, K., Saemundsen, A.K., Sullivan, J.L., Synnerholm, A.-C, Anvret, M., Pritchard, J., Sloper, C., Sieff, C., Pincott, J., Pachman, L., Rich, K., Cruzi, F., Cornet, J.A., Collins, R., Barnes, N., Knight, J., Sandstedt, B., and Klein, G. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological, and immunopathological studies. Cancer Res., 4l:4226, 1981.Google Scholar
  51. 51.
    Saemundsen, A.K., Purtilo, D.T., Sakamoto, K., Sullivan, J.L., Synnerholm, A.-C, Hanto, D.W., Simmons, R., Anvret, M., Collins, R., and Klein, G. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization. Cancer Res., 41:4237, 1981.PubMedGoogle Scholar
  52. 52.
    DeSchryver, A., Klein, G., Henle, G., Henle, W., Cameron, H.M., Santesson, L., and Clifford, P. Virus associated serology in malignant disease: antibody levels to viral capsid antigens (VCA), membrane antigens (MA) and early antigens (EA) in patients with various neoplastic conditions. Cancer, 9:353, 1972.Google Scholar
  53. 53.
    Levine, P.H., Connelly, R.R., Herberman, R.B., McCoy, J.L., and Fabrizio, P.L. Humoral and cellular immunity to EBV and lymphoid cell line antigens in human lymphoma. In: G. de The, H.A. Epstein, and H. zur Hausen (eds.), Oncogenesis and Herpesvirus II, Part 2: Epidemiology, Host, Response Control. pp. 225–235. Lyon: International Agency for Research on Cancer, 1975.Google Scholar
  54. 54.
    Payne, G.S., Bishop, J.M., and Varmus, H.E. Multiple arrangements of viral DNA and an activated host oncogene in bursal lymphomas. Nature, 295:209, 1982.PubMedCrossRefGoogle Scholar
  55. 55.
    Friedman-Kien, A.E., Laubenstein, L.J., Rubinstein, P., Buimovici-Klein, E., Marmor, M., Stahl, R., Spigland, I., Kwang, S.K., and Zolla-Pazner, S. Disseminated Kaposi’s sarcoma in homosexual men. Ann. Intern. Med., 96:693, 1982.PubMedGoogle Scholar
  56. 56.
    Goedert, J.J., Wallen, W.C., Mann, D.L., Strong, D.M., Neuland, C.Y., Greene, M.H., Murray, C., Fraumeni, J.F., Jr., and Blattner, W.A. Amyl nitrite may alter T lymphocytes in homosexual men. Lancet, i:412, 1982.CrossRefGoogle Scholar
  57. 57.
    Shearer, G.M. and Hurtenbach, U. Is sperm immunosuppressive in male homosexuals and vasectomized men? Immunol. Today, 3:153, 1982.CrossRefGoogle Scholar
  58. 58.
    Shulman, H.M., Sullivan, K.M., Weiden, P.L., McDonald, G.B., Striker, G.E., Sale, G.E., Hackman, R., Tsoi, M.-S., Storb, R., and Thomas, E.D. Chronic graft-versus-host syndrome in man. Am. J. Med., 69:204, 1980.PubMedCrossRefGoogle Scholar
  59. 59.
    Reinherz, E.L., Parkman, R., Rappeport, J., Rosen, F.S., and Schlossman, S.F. Aberrations of suppressor T cells in human graft-versus-host disease. N. Engl. J. Med., 300:1061, 1979.PubMedCrossRefGoogle Scholar
  60. 60.
    Saxon, A., Mclntyre, R.E., Stevens, R.H., and Gale, R.P. Lymphocyte dysfunction in chronic graft-versus host disease. Blood, 58:746, 1981.PubMedGoogle Scholar
  61. 61.
    Friedrich, W., O’Reilly, R.J., Koziner, B., Gebhard, D.F., Jr., Good, R.A., and Evans, R.L. T-lymphocyte reconstitution in recipients of bone marrow transplants with and without GVHD: imbalances of T-cell subpopulations having unique regulatory and cognitive functions. Blood, 59:696, 1982.PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1984

Authors and Affiliations

  • Donald Abrams
    • 1
  1. 1.Cancer Research InstituteUniversity of California San FranciscoSan FranciscoUSA

Personalised recommendations